20090114
 Study Confirms Antipsychotics Pose Heart Risk --- Latest Generation of Drugs Provides No Safety Advantage; Warning on Children, Elderly   By Tomsho, Robert, The Wall Street Journal,  Jan 15, 2009  Jerry Avorn, a professor of medicine at the Harvard Medical School and co-author of the editorial, said atypical antipsychotic drugs have been marketed as a safer alternative to older, more conventional medicines. Researchers say they are widely prescribed for off-label treatment of dementia in nursing-home patients and attention deficit hyperactivity disorder, or ADHD, in children.   
